目次

Table of Contents

Chapter 1. Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Service
1.1.2 Source
1.1.3 End User
1.1.4 Regional Scope
1.1.5 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.3.5.1 Data For Primary Interviews In North America
1.3.5.2 Data For Primary Interviews In Europe
1.3.5.3 Data For Primary Interviews In Asia Pacific
1.3.5.4 Data For Primary Interviews In Latin America
1.3.5.5 Data For Primary Interviews In Mea
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Volume Price Analysis (Model 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations

Chapter 2. Executive Summary
2.1 Market Outlook

Chapter 3. Large Molecule Drug Substance CDMO Market: Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Ancillary market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Variable Analysis
3.3.1 Market driver analysis
3.3.1.1 Increasing large molecule drug approvals
3.3.1.2 Rising incidence of infectious diseases,
3.3.1.3 Higher capital investments by pharma and biotech firms in advanced technologies for establishing partnerships with CDMOs
3.3.1.4 High demand for novel therapeutics
3.3.2 Market restraint analysis
3.3.2.1 Compliance issues while outsourcing
3.3.2.2 Changing scenarios within developing countries
3.3.2.3 Regulatory and legal compliance
3.4 Large Molecule Drug Substance CDMO Market: Analysis Tools
3.4.1 Porter’s Five Forces Analysis
3.4.2 Pestel Analysis
3.4.3 Major Deals & Strategic Alliances Analysis
3.4.3.1 Mergers And Acquisitions
3.4.3.2 Expansions
3.4.3.3 Agreement & Collaborations
3.4.3.4 Product & Service Launches
3.4.4 Market Entry Strategies
3.5 COVID-19 Impact Analysis

Chapter 4. Large Molecule Drug Substance CDMO Market: Services Segment Analysis
4.1 Large Molecule Drug Substance CDMO Market: Definition & Scope
4.2 Large Molecule Drug Substance CDMO Market: Market Share Analysis, 2021 & 2030
4.3 Contract Manufacturing
4.3.1 Contract Manufacturing Services Market, 2018 - 2030 (USD Billion)
4.3.2 Target Identification & Screening
4.3.2.1 Target Identification & Screening Market, 2018 - 2030 (USD Billion)
4.3.3 Target Validation & Functional Informatics
4.3.3.1 Target Validation & Functional Informatics Market, 2018 - 2030 (USD Billion)
4.3.4 Lead Identification & Candidate Optimization
4.3.4.1 Lead Identification & Candidate Optimization Market, 2018 - 2030 (USD Billion)
4.3.5 Preclinical Development
4.3.5.1 Preclinical Development Market, 2018 - 2030 (USD Billion)
4.4 Contract Development
4.4.1 Contract Development Market, 2018 - 2030 (USD Billion)
4.4.2 Cell Line Development
4.4.2.1 Cell Line Development Market, 2018 - 2030 (USD Billion)
4.4.3 Process Development
4.4.3.1 Process Development Market, 2018 - 2030 (USD Billion)

Chapter 5. Large Molecule Drug Substance CDMO Market: Source Segment Analysis
5.1 Large Molecule Drug Substance CDMO Market: Definition & Scope
5.2 Large Molecule Drug Substance CDMO Market: Market Share Analysis, 2021 & 2030
5.3 Mammalian
5.3.1 Mammalian Market, 2018 - 2030 (USD Billion)
5.4 Microbial
5.4.1 Microbial Market, 2018 - 2030 (USD Billion)
5.5 Others
5.5.1 Others Market, 2018 - 2030 (USD Billion)

Chapter 6. Large Molecule Drug Substance CDMO Market: End-user Segment Analysis
6.1 Large Molecule Drug Substance CDMO Market: Definition & Scope
6.2 Large Molecule Drug Substance CDMO Market: Market Share Analysis, 2021 & 2030
6.3 Biotech Companies
6.3.1 Biotech Companies Market, 2018 - 2030 (USD Billion)
6.4 CRO
6.4.1 CRO Market, 2018 - 2030 (USD Billion)
6.5 Others (Pharma Companies, Government, Research Institutes, Academic Institutes, Etc.)
6.5.1 Others (Pharma companies, Government, Research Institutes, Academic Institutes, Etc.) MARKET, 2018 - 2030 (USD Billion)

Chapter 7. Large Molecule Drug Substance CDMO Market: Regional Analysis
7.1 Large Molecule Drug Substance CDMO Market: Definition & Scope
7.2 Regional Market Snapshot
7.3 Regional Market Share and Leading Players, 2021
7.4 Large Molecule Drug Substance CDMO Market: Market Share Analysis, 2021 & 2030
7.5 North America
7.5.1 North America Large Molecule Drug Substance CDMO Market, 2018 - 2030 (USD Billion)
7.5.2 U.S.
7.5.2.1 U.S. Large Molecule Drug Substance CDMO Market, 2018 - 2030 (USD Billion)
7.5.3 Canada
7.5.3.1 Canada Large Molecule Drug Substance CDMO Market, 2018 - 2030 (USD Billion)
7.6 Europe
7.6.1 Europe Large Molecule Drug Substance CDMO Market, 2018 - 2030 (USD Billion)
7.6.2 France
7.6.2.1 France Large Molecule Drug Substance CDMO Market, 2018 - 2030 (USD Billion)
7.6.3 U.K.
7.7.3.1 U.K. Large Molecule Drug Substance CDMO Market, 2018 - 2030 (USD Billion)
7.6.4 Germany
7.6.4.1 Germany Large Molecule Drug Substance CDMO Market, 2018 - 2030 (USD Billion)
7.6.5 Italy
7.6.5.1 Italy Large Molecule Drug Substance CDMO Market, 2018 - 2030 (USD Billion)
7.6.7 Spain
7.6.7.1 Spain Large Molecule Drug Substance CDMO Market, 2018 - 2030 (USD Billion)
7.7 Asia Pacific
7.7.1 Asia Pacific Large Molecule Drug Substance CDMO Market, 2018 - 2030 (USD Billion)
7.7.2 Japan
7.7.2.1 Japan Large Molecule Drug Substance CDMO Market, 2018 - 2030 (USD Billion)
7.7.3 China
7.7.3.1 China Large Molecule Drug Substance CDMO Market, 2018 - 2030 (USD Billion)
7.7.4 India
7.7.4.1 India Large Molecule Drug Substance CDMO Market, 2018 - 2030 (USD Billion)
7.7.5 South Korea
7.7.5.1 Korea Large Molecule Drug Substance CDMO Market, 2018 - 2030 (USD Billion)
7.7.6 Australia
7.7.6.1 Australia Large Molecule Drug Substance CDMO Market, 2018 - 2030 (USD Billion)
7.8 Latin America
7.8.1 Latin America Large Molecule Drug Substance CDMO Market, 2018 - 2030 (USD Billion)
7.8.2 Brazil
7.8.2.1 Brazil Large Molecule Drug Substance CDMO Market, 2018 - 2030 (USD Billion)
7.8.3 Mexico
7.8.3.1 Mexico Large Molecule Drug Substance CDMO Market, 2018 - 2030 (USD Billion)
7.8.4 Argentina
7.8.4.1 Argentina Large Molecule Drug Substance CDMO Market, 2018 - 2030 (USD Billion)
7.8.5 Colombia
7.8.5.1 Colombia Large Molecule Drug Substance CDMO Market, 2018 - 2030 (USD Billion)
7.9 MEA
7.9.1 MEA Large Molecule Drug Substance CDMO Market, 2018 - 2030 (USD Billion)
7.9.2 South Africa
7.9.2.1 South Africa Large Molecule Drug Substance CDMO Market, 2018 - 2030 (USD Billion)
7.9.3 Saudi Arabia
7.9.3.1 Saudi Arabia Large Molecule Drug Substance CDMO Market, 2018 - 2030 (USD Billion)
7.9.4 UAE
7.9.4.1 UAE Large Molecule Drug Substance CDMO Market, 2018 - 2030 (USD Billion)

Chapter 8. Company Profiles
8.1.Thermo Fisher Scientific Inc.
8.1.1 Company Overview
8.1.2 Financial Performance
8.1.3 Service Benchmarking
8.1.4 Strategic Initiatives
8.2 Eurofins Scientific
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Service Benchmarking
8.2.4 Strategic Initiatives
8.3 WuXi Biologics
8.3.1 Company Overview
8.3.2 Financial Performance
8.3.3 Service Benchmarking
8.3.4 Strategic Initiatives
8.4 Samsung Biologics
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Service Benchmarking
8.4.4 Strategic Initiatives
8.5 Catalent, Inc
8.5.1 Company Overview
8.5.2 Financial Performance
8.5.3 Service Benchmarking
8.5.4 Strategic Initiatives
8.6 Cambrex Corporation
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.3 Service Benchmarking
8.6.4 Strategic initiatives
8.7 AGC Biologics
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Service Benchmarking
8.7.4 Strategic Initiatives
8.8 Recipharm AB (publ)
8.8.1 Company Overview
8.8.2 Financial Performance
8.8.3 Service Benchmarking
8.9 Siegfried Holding AG
8.9.1 Company Overview
8.9.2 Financial Performance
8.9.3 Service Benchmarking
8.9.4 Strategic Initiatives
8.10 Labcorp Drug Development
8.10.1 Company Overview
8.10.2 Service Benchmarking
8.10.3 Strategic Initiatives
8.11 FUJIFILM Diosynth Biotechnologies
8.11.1 Company Overview
8.11.2 Financial Performance
8.11.3 Service Benchmarking
8.11.4 Strategic Initiatives

List of Tables
Table 1 Global Large Molecule Drug Substance CDMO Market, by Region, 2018 - 2030 (USD Million)
Table 2 Global Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 3 Contract Manufacturing Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 4 Contract Development Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 5 Global Large Molecule Drug Substance CDMO Market, by Source, 2018 - 2030 (USD Million)
Table 6 Global Large Molecule Drug Substance CDMO Market, by End User, 2018 - 2030 (USD Million)
Table 7 North America Large Molecule Drug Substance CDMO Market, by Country, 2018 - 2030 (USD Million)
Table 8 North America Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 9 Contract Manufacturing Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 10 Contract Development Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 11 North America Large Molecule Drug Substance CDMO Market, by Source, 2018 - 2030 (USD Million)
Table 12 North America Large Molecule Drug Substance CDMO Market, by End User, 2018 - 2030 (USD Million)
Table 13 U.S. Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 14 U.S. Contract Manufacturing Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 15 U.S. Contract Development Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 16 U.S. Large Molecule Drug Substance CDMO Market, by Source, 2018 - 2030 (USD Million)
Table 17 U.S. Large Molecule Drug Substance CDMO Market, by End User, 2018 - 2030 (USD Million)
Table 18 Canada Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 19 Canada Contract Manufacturing Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 20 Canada Contract Development Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 21 Canada Large Molecule Drug Substance CDMO Market, by Source, 2018 - 2030 (USD Million)
Table 22 Canada Large Molecule Drug Substance CDMO Market, by End User, 2018 - 2030 (USD Million)
Table 23 Europe Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 24 Europe Contract Manufacturing Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 25 Europe Contract Development Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 26 Europe Large Molecule Drug Substance CDMO Market, by Source, 2018 - 2030 (USD Million)
Table 27 Europe Large Molecule Drug Substance CDMO Market, by End User, 2018 - 2030 (USD Million)
Table 28 Germany Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 29 Germany Contract Manufacturing Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 30 Germany Contract Development Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 31 Germany Large Molecule Drug Substance CDMO Market, by Source, 2018 - 2030 (USD Million)
Table 32 Germany Large Molecule Drug Substance CDMO Market, by End User, 2018 - 2030 (USD Million)
Table 33 France Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 34 France Contract Manufacturing Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 35 France Contract Development Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 36 France Large Molecule Drug Substance CDMO Market, by Source, 2018 - 2030 (USD Million)
Table 37 France Large Molecule Drug Substance CDMO Market, by End User, 2018 - 2030 (USD Million)
Table 38 Italy Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 39 Italy Contract Manufacturing Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 40 Italy Contract Development Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 41 Italy Large Molecule Drug Substance CDMO Market, by Source, 2018 - 2030 (USD Million)
Table 42 Italy Large Molecule Drug Substance CDMO Market, by End User, 2018 - 2030 (USD Million)
Table 43 Spain Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 44 Spain Contract Manufacturing Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 45 Spain Contract Development Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 46 Spain Large Molecule Drug Substance CDMO Market, by Source, 2018 - 2030 (USD Million)
Table 47 Spain Large Molecule Drug Substance CDMO Market, by End User, 2018 - 2030 (USD Million)
Table 48 U.K. Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 49 U.K. Contract Manufacturing Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 50 U.K. Contract Development Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 51 U.K. Large Molecule Drug Substance CDMO Market, by Source, 2018 - 2030 (USD Million)
Table 52 U.K. Large Molecule Drug Substance CDMO Market, by End User, 2018 - 2030 (USD Million)
Table 53 Asia Pacific Large Molecule Drug Substance CDMO Market, by Country, 2018 - 2030 (USD Million)
Table 54 Asia Pacific Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 55 Contract Manufacturing Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 56 Contract Development Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 57 Asia Pacific Large Molecule Drug Substance CDMO Market, by Source, 2018 - 2030 (USD Million)
Table 58 Asia Pacific Large Molecule Drug Substance CDMO Market, by End User, 2018 - 2030 (USD Million)
Table 59 Japan Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 60 Japan Contract Manufacturing Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 61 Japan Contract Development Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 62 Japan Large Molecule Drug Substance CDMO Market, by Source, 2018 - 2030 (USD Million)
Table 63 Japan Large Molecule Drug Substance CDMO Market, by End User, 2018 - 2030 (USD Million)
Table 64 India Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 65 India Contract Manufacturing Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 66 India Contract Development Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 67 India Large Molecule Drug Substance CDMO Market, by Source, 2018 - 2030 (USD Million)
Table 68 India Large Molecule Drug Substance CDMO Market, by End User, 2018 - 2030 (USD Million)
Table 69 China Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 70 China Contract Manufacturing Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 71 China Contract Development Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 72 China Large Molecule Drug Substance CDMO Market, by Source, 2018 - 2030 (USD Million)
Table 73 China Large Molecule Drug Substance CDMO Market, by End User, 2018 - 2030 (USD Million)
Table 74 South Korea Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 75 South Korea Contract Manufacturing Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 76 South Korea Contract Development Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 77 South Korea Large Molecule Drug Substance CDMO Market, by Source, 2018 - 2030 (USD Million)
Table 78 South Korea Large Molecule Drug Substance CDMO Market, by End User, 2018 - 2030 (USD Million)
Table 79 Australia Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 80 Australia Contract Manufacturing Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 81 Australia Contract Development Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 82 Australia Large Molecule Drug Substance CDMO Market, by Source, 2018 - 2030 (USD Million)
Table 83 Australia Large Molecule Drug Substance CDMO Market, by End User, 2018 - 2030 (USD Million)
Table 84 Latin America Large Molecule Drug Substance CDMO Market, by Country, 2018 - 2030 (USD Million)
Table 85 Latin America Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 86 Contract Manufacturing Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 87 Contract Development Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 88 Latin America Large Molecule Drug Substance CDMO Market, by Source, 2018 - 2030 (USD Million)
Table 89 Latin America Large Molecule Drug Substance CDMO Market, by End User, 2018 - 2030 (USD Million)
Table 90 Brazil Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 91 Brazil Contract Manufacturing Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 92 Brazil Contract Development Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 93 Brazil Large Molecule Drug Substance CDMO Market, by Source, 2018 - 2030 (USD Million)
Table 94 Brazil Large Molecule Drug Substance CDMO Market, by End User, 2018 - 2030 (USD Million)
Table 95 Mexico Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 96 Mexico Contract Manufacturing Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 97 Mexico Contract Development Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 98 Mexico Large Molecule Drug Substance CDMO Market, by Source, 2018 - 2030 (USD Million)
Table 99 Mexico Large Molecule Drug Substance CDMO Market, by End User, 2018 - 2030 (USD Million)
Table 100 Argentina Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 101 Argentina Contract Manufacturing Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 102 Argentina Contract Development Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 103 Argentina Large Molecule Drug Substance CDMO Market, by Source, 2018 - 2030 (USD Million)
Table 104 Argentina Large Molecule Drug Substance CDMO Market, by End User, 2018 - 2030 (USD Million)
Table 105 Colombia Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 106 Colombia Contract Manufacturing Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 107 Colombia Contract Development Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 108 Colombia Large Molecule Drug Substance CDMO Market, by Source, 2018 - 2030 (USD Million)
Table 109 Colombia Large Molecule Drug Substance CDMO Market, by End User, 2018 - 2030 (USD Million)
Table 110 MEA Large Molecule Drug Substance CDMO Market, by Country, 2018 - 2030 (USD Million)
Table 111 MEA Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 112 Contract Manufacturing Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 113 Contract Development Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 114 MEA Large Molecule Drug Substance CDMO Market, by Source, 2018 - 2030 (USD Million)
Table 115 MEA Large Molecule Drug Substance CDMO Market, by End User, 2018 - 2030 (USD Million)
Table 116 South Africa Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 117 South Africa Contract Manufacturing Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 118 South Africa Contract Development Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 119 South Africa Large Molecule Drug Substance CDMO Market, by Source, 2018 - 2030 (USD Million)
Table 120 South Africa Large Molecule Drug Substance CDMO Market, by End User, 2018 - 2030 (USD Million)
Table 121 Saudi Arabia Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 122 Saudi Arabia Contract Manufacturing Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 123 Saudi Arabia Contract Development Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 124 Saudi Arabia Large Molecule Drug Substance CDMO Market, by Source, 2018 - 2030 (USD Million)
Table 125 Saudi Arabia Large Molecule Drug Substance CDMO Market, by End User, 2018 - 2030 (USD Million)
Table 126 UAE Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 127 UAE Contract Manufacturing Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 128 UAE Contract Development Large Molecule Drug Substance CDMO Market, by Service, 2018 - 2030 (USD Million)
Table 129 UAE Large Molecule Drug Substance CDMO Market, by Source, 2018 - 2030 (USD Million)
Table 130 UAE Large Molecule Drug Substance CDMO Market, by End User, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in Asia Pacific
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Commodity Flow Analysis
Fig. 14 Volume Price Analysis
Fig. 15 Large Molecule Drug Substance CDMO market snapshot (2021)
Fig. 16 Large Molecule Drug Substance CDMO market segmentation
Fig. 17 Large Molecule Drug Substance CDMO market: Strategy framework
Fig. 18 Parent market outlook
Fig. 19 Related/ancillary market outlook
Fig. 20 Penetration & growth prospect mapping
Fig. 21 Market driver relevance analysis (Current & future impact)
Fig. 22 Current shared services and outsourcing usage levels
Fig. 23 Market restraint relevance analysis (Current & future impact)
Fig. 24 Porter’s five forces analysis
Fig. 25 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 26 Large Molecule Drug Substance CDMO market service outlook: Segment Dashboard
Fig. 27 Large Molecule Drug Substance CDMO market: Services movement analysis
Fig. 28 Contract Manufacturing market, 2018 - 2030 (USD Billion)
Fig. 29 Target Identification & Screening market, 2018 - 2030 (USD Billion)
Fig. 30 Lead Identification & Candidate Optimization market, 2018 - 2030 (USD Billion)
Fig. 31 Preclinical Development market, 2018 - 2030 (USD Billion)
Fig. 32 Contract Development market, 2018 - 2030 (USD Billion)
Fig. 33 Cell Line Development market, 2018 - 2030 (USD Billion)
Fig. 34 Process Development market, 2018 - 2030 (USD Billion)
Fig. 35 Large Molecule Drug Substance CDMO market source outlook: Segment Dashboard
Fig. 36 Large Molecule Drug Substance CDMO market: Source movement analysis
Fig. 37 Mammalian market, 2018 - 2030 (USD Billion)
Fig. 38 Microbial market, 2018 - 2030 (USD Billion)
Fig. 39 Others market, 2018 - 2030 (USD Billion)
Fig. 40 Large Molecule Drug Substance CDMO market end user outlook: Segment Dashboard
Fig. 41 Large Molecule Drug Substance CDMO market: End User movement analysis
Fig. 42 Biotech Companies market, 2018 - 2030 (USD Billion)
Fig. 43 CRO market, 2018 - 2030 (USD Billion)
Fig. 44 Others (Pharma companies, Government, Research Institutes, Academic Institutes, Etc.) market, 2018 - 2030 (USD Billion)
Fig. 45 Regional market place: Dashboard
Fig. 46 Large Molecule Drug Substance CDMO Market: Definition & Scope
Fig. 47 Regional Market Snapshot (Figures in USD Billion, 2021)
Fig. 48 Regional Market Share, 2021 (USD Billion)
Fig. 49 Regional outlook, 2021 & 2030
Fig. 50 North America market, 2018 - 2030 (USD Billion)
Fig. 51 U.S. market, 2018 - 2030 (USD Billion)
Fig. 52 Canada market, 2018 - 2030 (USD Billion)
Fig. 53 Europe market, 2018 - 2030 (USD Billion)
Fig. 54 France market, 2018 - 2030 (USD Billion)
Fig. 55 U.K. market, 2018 - 2030 (USD Billion)
Fig. 56 Germany market, 2018 - 2030 (USD Billion)
Fig. 57 Italy market, 2018 - 2030 (USD Billion)
Fig. 58 Spain market, 2018 - 2030 (USD Billion)
Fig. 59 Asia Pacific market, 2018 - 2030 (USD Billion)
Fig. 60 Japan market, 2018 - 2030 (USD Billion)
Fig. 61 China market, 2018 - 2030 (USD Billion)
Fig. 62 India market, 2018 - 2030 (USD Billion)
Fig. 63 Korea market, 2018 - 2030 (USD Billion)
Fig. 64 Australia market, 2018 - 2030 (USD Billion)
Fig. 65 Latin America market, 2018 - 2030 (USD Billion)
Fig. 66 Brazil market, 2018 - 2030 (USD Billion)
Fig. 67 Mexico market, 2018 - 2030 (USD Billion)
Fig. 68 Argentina market, 2018 - 2030 (USD Billion)
Fig. 69 Colombia market, 2018 - 2030 (USD Billion)
Fig. 70 MEA market, 2018 - 2030 (USD Billion)
Fig. 71 South Africa market, 2018 - 2030 (USD Billion)
Fig. 72 Saudi Arabia market, 2018 - 2030 (USD Billion)
Fig. 73 UAE market, 2018 - 2030 (USD Billion)